1 completed, 1 not yet recruiting. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 3 | 2 | Completed 1, Not yet recruiting 1 |
Follow Cardiovascular Diseases (CVD): new trials by email Literature Review of Cardiovascular Diseases (CVD) trials Research Report on Cardiovascular Diseases (CVD)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Reducing Arterial Inflammation Using Eplerenone and Statins in HIV Eplerenone, Placebo - HIV (Human Immunodeficiency Virus), Cardiovascular Diseases (CVD) | Phase 2 / Phase 3 | Not yet recruiting | Massachusetts General Hospital | 124 | 2027-03-01 | 2026-10-23 |
| Comparative Study Between Antihyperlipidemic Agents in Treatment of Cardiovascular Diseases rosuvastatin drug, Patients received rosuvastatin ezetimibe10/10mg - Cardiovascular Diseases (CVD) | Phase 2 / Phase 3 | Completed | Beni-Suef University | 66 | 2024-12-15 | 2026-01-05 |
Cardiovascular Diseases (2) · Acquired Immunodeficiency Syndrome (1) · Arteritis (1) · Heart Diseases (1)
Blood-Borne Infections (1) · Communicable Diseases (1) · Genital Diseases (1) · HIV Infections (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1) · Infections (1) · Lentivirus Infections (1) · RNA Virus Infections (1) · Retroviridae Infections (1) · Sexually Transmitted Diseases (1) · Sexually Transmitted Diseases, Viral (1) · Slow Virus Diseases (1) · Urogenital Diseases (1) · Vascular Diseases (1)
Eplerenone (1)
Beni-Suef University (1) · Massachusetts General Hospital (1)
Egypt (1) · United States (1)